Physician profile
Jonathan T Deland
NPI 1386651644
$4,008,559.16
in general payments reported to CMS, 2019-2025
10 companies · $478K in 2025
The $478K reported for 2025 was more than what 99% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790K · 2020: $326K · 2021: $474K · 2022: $586K · 2023: $717K · 2024: $637K · 2025: $478K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.8M · Consulting Fee: $28K · Travel and Lodging: $11K · Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,791,958.56 |
| Consulting Fee | $28,267.00 |
| Travel and Lodging | $11,218.52 |
| Food and Beverage | $701.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,483,241.26 | 2019-2025 | Arthrex |
| Limacorporate S.P.A. | $477,506.43 | 2019-2022 | |
| Paragon 28, INC. | $25,586.27 | 2019-2025 | Portfolio, Smart28 |
| Encore Medical, Lp | $16,667.00 | 2025 | |
| Lima USA, INC. | $2,556.69 | 2021-2022 | |
| Wright Medical Technology, INC. | $2,300.00 | 2019 | |
| Stryker Corporation | $499.91 | 2022-2025 | Inbone |
| Exactech, INC. | $124.97 | 2019 | |
| Zimmer Biomet Holdings, INC. | $59.38 | 2021 | |
| Amgen INC. | $17.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Deland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.